These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 32762488

  • 1. COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.
    Dersch R, Wehrum T, Fähndrich S, Engelhardt M, Rauer S, Berger B.
    Mult Scler; 2020 Sep; 26(10):1264-1266. PubMed ID: 32762488
    [Abstract] [Full Text] [Related]

  • 2. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.
    Carandini T, Pietroboni AM, Sacchi L, De Riz MA, Pozzato M, Arighi A, Fumagalli GG, Martinelli Boneschi F, Galimberti D, Scarpini E.
    Mult Scler; 2020 Sep; 26(10):1268-1269. PubMed ID: 32463329
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.
    Ghajarzadeh M, Mirmosayyeb O, Barzegar M, Nehzat N, Vaheb S, Shaygannejad V, Maghzi AH.
    Mult Scler Relat Disord; 2020 Aug; 43():102222. PubMed ID: 32464586
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
    Foerch C, Friedauer L, Bauer B, Wolf T, Adam EH.
    Mult Scler Relat Disord; 2020 Jul; 42():102180. PubMed ID: 32408155
    [Abstract] [Full Text] [Related]

  • 11. COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?
    Brownlee WJ.
    Mult Scler; 2020 Sep; 26(10):1267. PubMed ID: 32762499
    [No Abstract] [Full Text] [Related]

  • 12. Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis.
    Devogelaere J, D'hooghe MB, Vanderhauwaert F, D'haeseleer M.
    Neurol Sci; 2020 Aug; 41(8):1981-1983. PubMed ID: 32564270
    [Abstract] [Full Text] [Related]

  • 13. COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.
    Fernández-Díaz E, Gracia-Gil J, García-García JG, Palao M, Romero-Sánchez CM, Segura T.
    Mult Scler Relat Disord; 2020 Oct; 45():102402. PubMed ID: 32711297
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis.
    Cook S, Leist T, Comi G, Montalban X, Giovannoni G, Nolting A, Hicking C, Galazka A, Sylvester E.
    Mult Scler Relat Disord; 2019 Apr; 29():157-167. PubMed ID: 30885374
    [Abstract] [Full Text] [Related]

  • 18. COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach.
    Borriello G, Ianniello A.
    Mult Scler Relat Disord; 2020 Jun; 41():102165. PubMed ID: 32388451
    [Abstract] [Full Text] [Related]

  • 19. COVID-19 and rheumatology: is shielding really necessary?
    Amani L, Warraich R, Patel N, Tahir H.
    Br J Hosp Med (Lond); 2020 Jun 02; 81(6):1-3. PubMed ID: 32589537
    [Abstract] [Full Text] [Related]

  • 20. Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab.
    Iannetta M, Cesta N, Stingone C, Malagnino V, Teti E, Vitale P, De Simone G, Rossi B, Ansaldo L, Compagno M, Spalliera I, Di Lorenzo A, Landi D, Nicoletti CG, Marfia GA, Andreoni M, Sarmati L.
    Mult Scler Relat Disord; 2020 Oct 02; 45():102442. PubMed ID: 32777745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.